Triveni Bio

Developer of functional antibodies for the treatment of immunological and inflammatory disorders

placeWaltham, Massachusetts, United States calendar_todayFounded 2023 language triveni.bio

Innovation

10 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 34 times.

YearFilings
20243
20258
20267

Investor mix

10 investors on record; lead investors include Atlas Venture, Cormorant Asset Management, Goldman Sachs.

Investor typeCountShare
Venture capital440%
Private equity220%
Bank & private debt110%
Other / undisclosed330%
Coming soon